Purple Biotech Ltd (TLV:PPBT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.300
+0.100 (8.33%)
At close: Dec 4, 2025
-88.29%
Market Cap 24.16M
Revenue (ttm) n/a
Net Income (ttm) -10.76M
Shares Out 1.86B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,074,614
Average Volume 4,137,480
Open 1.200
Previous Close 1.200
Day's Range 1.200 - 1.300
52-Week Range 1.000 - 12.200
Beta -0.70
RSI 52.91
Earnings Date Nov 6, 2025

About Purple Biotech

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin recept... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1968
Employees 9
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PPBT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.